-
Product Insights
NewFisher & Paykel Healthcare Corporation Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Fisher & Paykel Healthcare Corporation Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Fisher & Paykel Healthcare Corporation Ltd (Fisher & Paykel) designs, manufactures, and commercializes products and systems for use in acute care, respiratory care, and obstructive sleep apnea. The company offers breathing circuits, chambers, continuous positive airway pressure devices, humidifiers, nasal cannula, infant resuscitators, infant warmers, interfaces, masks, software and data management, surgical devices, and accessories for...
-
Product Insights
NewInspire Medical Systems Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Inspire Medical Systems Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Inspire Medical Systems Inc (Inspire) is a medical technology company. It focuses on the development of solutions for patients with obstructive sleep apnea (OSA). The company offers a neurostimulation technology that provides moderate to severe OSA treatment. It also develops solutions to monitor a patient’s breathing and deliver mild hypoglossal nerve stimulation to maintain an open airway. Inspire...
-
Product Insights
NewResMed Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our ResMed Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. ResMed Inc (ResMed) develops, manufactures, and distributes medical equipment for the diagnosis, treatment and management respiratory disorders such as sleep-disordered breathing (SDB), sleep apnea and chronic obstructive pulmonary disease (COPD). Its major products include air flow generators such as continuous positive airway pressure (CPAP) devices, auto-bilevel devices, variable positive airway pressure (VPAP) devices, automatic positive airway pressure (APAP) devices, humidifiers,...
-
Product Insights
Likelihood of Approval Analysis for Bone Marrow Transplant Rejection
Overview How likely is it that the drugs in Bone Marrow Transplant Rejection will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bone Marrow Transplant Rejection Overview Bone marrow transplant rejection is...
-
Product Insights
Likelihood of Approval Analysis for Graft Versus Host Disease (GVHD)
Overview How likely is it that the drugs in Graft Versus Host Disease (GVHD) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Graft Versus Host Disease (GVHD) Overview Graft-versus-host disease (GVHD)...
-
Product Insights
Likelihood of Approval Analysis for Grass Pollen Allergy
Overview How likely is it that the drugs in Grass Pollen Allergy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Grass Pollen Allergy Overview Grass pollen allergy is a reaction which...
-
Product Insights
Likelihood of Approval Analysis for Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
Overview How likely is it that the drugs in Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hereditary Angioedema (HAE) (C1 Esterase Inhibitor...
-
Product Insights
Likelihood of Approval Analysis for Anemia in Chronic Kidney Disease (Renal Anemia)
Overview How likely is it that the drugs in Anemia in Chronic Kidney Disease (Renal Anemia) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anemia in Chronic Kidney Disease (Renal Anemia)...
-
Product Insights
Likelihood of Approval Analysis for Systemic Mastocytosis
Overview How likely is it that the drugs in Systemic Mastocytosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Systemic Mastocytosis Overview Systemic mastocytosis is a disorder where mast cells are...
-
Product Insights
Likelihood of Approval Analysis for Paroxysmal Nocturnal Hemoglobinuria
Overview How likely is it that the drugs in Paroxysmal Nocturnal Hemoglobinuria will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Paroxysmal Nocturnal Hemoglobinuria Overview Paroxysmal nocturnal hemoglobinuria is a rare disease...